Connection

Fengcai Zhu to Pneumonia, Viral

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about Pneumonia, Viral.
Fengcai Zhu
Connection Strength
0.085
Pneumonia, Viral
  1. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 08 15; 396(10249):479-488.
    View in: PubMed
    Score: 0.028
  2. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 06 13; 395(10240):1845-1854.
    View in: PubMed
    Score: 0.028
  3. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020 08 04; 222(5):746-754.
    View in: PubMed
    Score: 0.007
  4. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Virology. 2020 10; 549:1-4.
    View in: PubMed
    Score: 0.007
  5. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020 08; 285:198005.
    View in: PubMed
    Score: 0.007
  6. Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020 07; 546:122-126.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.